US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents

Patent application publication

US8999996B2 - Hydrazide containing nuclear transport modulators and uses thereof - Google Patents

US10808039B2 - Monomethylvaline compounds capable of conjugation to ligands - Google Patents

US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

TW202113082A - Antisense oligonucleotides targeting atxn3 - Google Patents

Ataxin 3 - an overview

ATXN3 Gene - GeneCards, ATX3 Protein

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

US7612114B2 - Selective estrogen receptor modulator - Google Patents

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

US7417042B2 - Compounds for enzyme inhibition - Google Patents

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect